Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × atezolizumab × Clear all

NCT04338269 2026-03-19

CONTACT-03

Phase 3 Terminated

522 enrolled 22 charts

Carcinoma, Renal Cell

NCT03024996 2023-08-03

IMmotion010

Phase 3 Terminated

778 enrolled 19 charts

Carcinoma, Renal Cell

NCT02420821 2023-01-30

IMmotion151

Phase 3 Completed

915 enrolled 40 charts

Carcinoma, Renal Cell

NCT03693573 2018-11-15

A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Phase 3 Withdrawn

Carcinoma, Renal Cell